Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Depreciation & Amortization (CF) (2016 - 2025)

OptimizeRx (OPRX) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 1.46% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, changed 0.07% year-over-year, with the annual reading at $4.3 million for FY2025, 0.05% changed from the prior year.
  • Depreciation & Amortization (CF) hit $1.1 million in Q4 2025 for OptimizeRx, roughly flat from $1.1 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.1 million in Q3 2024 to a low of $385152.0 in Q4 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $777289.8 across 5 years, with a median of $792558.0 in 2022.
  • Biggest five-year swings in Depreciation & Amortization (CF): fell 19.57% in 2023 and later surged 134.48% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $385152.0 in 2021, then grew by 18.54% to $456545.0 in 2022, then skyrocketed by 120.57% to $1.0 million in 2023, then grew by 8.64% to $1.1 million in 2024, then dropped by 1.46% to $1.1 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for OPRX at $1.1 million in Q4 2025, $1.1 million in Q3 2025, and $1.1 million in Q2 2025.